Xeris Biopharma Holdings, Inc. Annual Return On Equity in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Xeris Biopharma Holdings, Inc. quarterly/annual Return On Equity history and growth rate from 2020 to 2023.
  • Xeris Biopharma Holdings, Inc. Return On Equity for the quarter ending September 30, 2024 was 397 %.
  • Xeris Biopharma Holdings, Inc. annual Return On Equity for 2023 was -611 %, a 337% decline from 2022.
  • Xeris Biopharma Holdings, Inc. annual Return On Equity for 2022 was -140 %, a 55.2% increase from 2021.
  • Xeris Biopharma Holdings, Inc. annual Return On Equity for 2021 was -313 %, a 14.6% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -611 -471 -337% Jan 1, 2023 Dec 31, 2023
2022 -140 +173 +55.2% Jan 1, 2022 Dec 31, 2022
2021 -313 +53.6 +14.6% Jan 1, 2021 Dec 31, 2021
2020 -366 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.